wockhardt-in-irish-pharmaceutical-deal

Wockhardt in Irish pharmaceutical deal

India's Wockhardt closes its fourth European acquisition paying $150 million for Pinewood Laboratories of Ireland.
Wockhardt has acquired IrelandÆs Pinewood Laboratories for $150 million in an all-cash deal. Pinewood is a branded, generic pharmaceutical company, which registered a turnover of $70 million for the financial year ending June 2006. With this acquisition, Wockhardt's total sales derived from Europe will increase to more than $200 million, representing almost half the Indian companyÆs turnover.

The acquisition also expands Wockhardt's European footprint to encompass Ireland. Wockhardt acquired Wallis Laboratories in 1998 and CP Pharmaceuticals in 2002, both in the UK. In 2004 it acquired Esparma of Germany. Through its three earlier acquisitions, Wockhardt had already created a meaningful European presence and has been successful in extracting value out of the acquisitions by...
¬ Haymarket Media Limited. All rights reserved.

FinanceAsia has updated its subscription model.

Registered readers now have the opportunity to read 5 articles from our award-winning website for free.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team (2-10 users), or office-wide licences.

To help you and your colleagues access our proprietary content, please contact us at subscriptions@financeasia.com, or +(852) 2122 5222

Article limit is reached.

Hello! You have used up all of your free articles on FinanceAsia.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team (2-10 users), or office-wide licences. To help you and your colleagues access our proprietary content, please contact us at subscriptions@financeasia.com, or +(852) 2122 5222